focus -WSS

focus

author：focus 2025-08-12 11:29:28 - browse：321

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Congress may force more Covid

focus

WSS

Secretariat’s lessons for human medicine

New study raises questions about niacin and heart health

Heat waves linked to early deliveries, preterm births in new study

Average age of first period drops to 11.9 years, study shows

David Sabatini, ex

WATCH: Why do our ears pop?

hotspot

focus

focus

Walensky prepares to leave CDC — and Congress — behind

Lab trade group sues FDA to halt regulation of lab

Heart attack and stroke risk calculators need revising

Adam's Biotech Scorecard: Do Sarepta's exon

Bright Health sells Medicare Advantage business to Molina

Abridge raises $150m as clinical notes automation market heats up

Sports medicine is finally prioritizing gender equality

Antibiotic resistance nearly killed me, so I'm raising awareness of it

The high cost of giving birth even with insurance

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

hotspot

Prosthetic arm enables patients to feel the objects they grip

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Dark money group runs ads on China biotech bill

Flagship Pioneering startup Sonata Therapeutics lays off 21

David Sabatini, ex

MD Anderson's Padmanee Sharma responds to research credit suit

focus

hotspot

hotspot

leisure time